Medicare

Commentary

Massive coverage losses are greatly exaggerated

Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary

Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation

This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary

Supreme Court and ObamaCare – here’s what to expect if law is not upheld

The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
Commentary

How Trump can trounce Biden on healthcare

In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Commentary

Fans of Medicare for All Have an Ally in Biden

So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Commentary

Medicare for none – these are the reforms we need to keep program solvent

Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
California

Keep the government out of pharmaceutical drug manufacturing

Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
Commentary

Massive coverage losses are greatly exaggerated

Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary

Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation

This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary

Supreme Court and ObamaCare – here’s what to expect if law is not upheld

The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
Commentary

How Trump can trounce Biden on healthcare

In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Commentary

Fans of Medicare for All Have an Ally in Biden

So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Commentary

Medicare for none – these are the reforms we need to keep program solvent

Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
California

Keep the government out of pharmaceutical drug manufacturing

Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
Scroll to Top